As of 2024-12-12, the Relative Valuation of Sensei Biotherapeutics Inc (SNSE) is (21.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of Sensei Biotherapeutics Inc based on Relative Valuation is -5139.4%.
The range of the Relative Valuation is (21.45) - (23.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 24.9x | 18.3x |
| Forward P/E multiples | 12.5x - 19.4x | 18.7x |
| Fair Price | (21.45) - (23.01) | (21.92) |
| Upside | -5030.4% - -5390.0% | -5139.4% |
| Date | P/E |
| 2024-12-03 | -0.44 |
| 2024-12-02 | -0.46 |
| 2024-11-29 | -0.46 |
| 2024-11-27 | -0.47 |
| 2024-11-26 | -0.45 |
| 2024-11-25 | -0.51 |
| 2024-11-22 | -0.44 |
| 2024-11-21 | -0.41 |
| 2024-11-20 | -0.42 |
| 2024-11-19 | -0.41 |
| 2024-11-18 | -0.42 |
| 2024-11-15 | -0.38 |
| 2024-11-14 | -0.39 |
| 2024-11-13 | -0.45 |
| 2024-11-12 | -0.46 |
| 2024-11-11 | -0.46 |
| 2024-11-08 | -0.47 |
| 2024-11-07 | -0.46 |
| 2024-11-06 | -0.44 |
| 2024-11-05 | -0.42 |
| 2024-11-04 | -0.44 |
| 2024-11-01 | -0.41 |
| 2024-10-31 | -0.40 |
| 2024-10-30 | -0.48 |
| 2024-10-29 | -0.50 |
| 2024-10-28 | -0.50 |
| 2024-10-25 | -0.47 |
| 2024-10-24 | -0.50 |
| 2024-10-23 | -0.48 |
| 2024-10-22 | -0.52 |
| 2024-10-21 | -0.66 |
| 2024-10-18 | -0.35 |
| 2024-10-17 | -0.36 |
| 2024-10-16 | -0.39 |
| 2024-10-15 | -0.39 |
| 2024-10-14 | -0.38 |
| 2024-10-11 | -0.40 |
| 2024-10-10 | -0.40 |
| 2024-10-09 | -0.38 |
| 2024-10-08 | -0.40 |
| 2024-10-07 | -0.43 |
| 2024-10-04 | -0.42 |
| 2024-10-03 | -0.41 |
| 2024-10-02 | -0.43 |
| 2024-10-01 | -0.42 |
| 2024-09-30 | -0.50 |
| 2024-09-27 | -0.47 |
| 2024-09-26 | -0.47 |
| 2024-09-25 | -0.43 |
| 2024-09-24 | -0.45 |